Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are scheduled for a non-emergency robotic prostate removal surgery
- People (or their legal representatives) who are able to give written consent to take part in the study
- Males between 18 and 75 years of age
- People who do not have significant mental health conditions that could affect their ability to understand the procedure or follow medical instructions and attend appointments
- People whose overall health is rated as Class I, II, or III by an anaesthesiologist — meaning their general health ranges from very good to having some controlled medical conditions (confirm with trial site)
Who may not be able to join:
- People who have taken part in another clinical trial within the 90 days before screening, or who are currently in another trial (unless approved by the study team)
- People who need any additional surgical procedures beyond prostate removal and/or removal of nearby lymph nodes
- People who have previously had pelvic surgery, or surgery related to weight loss that affects how the body absorbs food
- People who are unable to give informed consent
- People who are unwilling or unable to attend follow-up appointments and examinations
- People with poorly controlled high blood pressure or high blood sugar levels that are above specific thresholds
- People whose overall health is rated as Class IV or higher by an anaesthesiologist, indicating serious health conditions
- People with a history of ongoing alcohol or drug misuse within the 2 years before screening
- People with chronic kidney failure or who are on dialysis
- People with a significant or complex medical history, or a weakened immune system
- People with a pre-existing autoimmune or connective tissue disease, such as lupus or scleroderma
- People whose immune system is weakened due to long-term steroid use, chemotherapy, or immune deficiency conditions
- People with any medical condition that would prevent them from following the study requirements
- People with any other serious, unstable, or life-threatening medical condition that the study doctor believes could put their wellbeing at risk or affect the safety of the study
- People who currently use or have previously regularly used pain relief medication
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +441438284042
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recruitment rates; Evaluate treatment-based adverse events, serious adverse events, anticipated adverse device effects, unanticipated adverse device effects and all device deficiencies and use errors, regardless of relationship to an adverse event.; Pre-op vitals; Pre-op BMI (height and weight); Pre-op labs; Insufflation Pressure; Estimated blood loss; Blood transfusion; Procedure time (initial incision to closure); Surgeon-determined need to increase IAP beyond "study pressure"; Administration of transversus abdominis plane block; Anesthetic/pain medication administration; MedaSense PMD-200 m...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.